DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by StockNews.com

StockNews.com lowered shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research note released on Friday morning.

A number of other equities research analysts have also issued reports on XRAY. Evercore ISI reduced their price target on DENTSPLY SIRONA from $40.00 to $35.00 and set an outperform rating on the stock in a research report on Friday. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They issued an outperform rating and a $42.00 target price on the stock. Piper Sandler reiterated a neutral rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research report on Friday. Finally, Leerink Partnrs reaffirmed an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and an average target price of $35.89.

DENTSPLY SIRONA Trading Down 0.3 %

Shares of XRAY stock opened at $28.29 on Friday. The stock has a market capitalization of $5.87 billion, a P/E ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a fifty-two week low of $26.27 and a fifty-two week high of $41.65. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.95 and a current ratio of 1.43. The company has a 50 day moving average price of $32.13 and a 200 day moving average price of $32.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The business had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.39 earnings per share. Equities research analysts predict that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.26%. The ex-dividend date was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Exchange Traded Concepts LLC raised its holdings in shares of DENTSPLY SIRONA by 41.2% in the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 439 shares during the last quarter. Asset Management One Co. Ltd. raised its stake in DENTSPLY SIRONA by 5.0% during the 3rd quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after acquiring an additional 4,294 shares during the last quarter. Xponance Inc. lifted its position in DENTSPLY SIRONA by 12.4% during the 3rd quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock worth $1,274,000 after acquiring an additional 4,114 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of DENTSPLY SIRONA by 132.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock valued at $2,863,000 after purchasing an additional 47,748 shares during the last quarter. Finally, Strs Ohio increased its holdings in shares of DENTSPLY SIRONA by 14.6% in the third quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock valued at $1,611,000 after purchasing an additional 6,021 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.